Sunstone Therapies Announces Publication of Positive Phase 2 Study Results in Cancer
18 déc. 2023 07h00 HE
|
Sunstone Therapies
Sunstone Therapies Announces Publication of Positive Phase 2 Study Results in Cancer Phase 2 trial demonstrated the safety and efficacy of psilocybin-assisted group therapy for...
Beckley Academy Welcomes New Faculty for 2024 Psychedelic Therapy Practitioners Courses
14 déc. 2023 09h00 HE
|
Beckley Academy
Beckley Academy Welcomes New Faculty for 2024 Psychedelic Therapy Practitioners Courses
Sunstone Therapies Celebrates Three Year Anniversary With More Than 100 Psychedelic-Assisted Therapy Treatments Completed
14 déc. 2023 07h00 HE
|
Sunstone Therapies
Sunstone Therapies Celebrates Three Year Anniversary With More Than 100 Psychedelic-Assisted Therapy Treatments Completed Sunstone has developed an unrivalled expertise and experience in...
Beckley Retreats Announces Expanded Scholarship Program, Alongside New Specialty Programs for Underserved Communities
11 déc. 2023 11h27 HE
|
Beckley Retreats
Beckley Retreats Announces Expanded Scholarship Program, Alongside New Specialty Programs for Underserved Communities
Optimi Health and Sunshine Earth Labs Ltd. Forge Strategic Supply Agreement
07 déc. 2023 07h30 HE
|
Optimi Health Corp.
Optimi Health and Sunshine Earth Labs Ltd. Forge Strategic Supply Agreement
PharmAla Biotech and Filament Health Announce Release of Second Batch of GMP MDMA Capsules
15 nov. 2023 08h55 HE
|
PharmAla Biotech
PharmAla Biotech contracted with Filament Health to manufacture a second batch of MDMA capsules; manufacturing is complete and shipped to clients.
World’s First Observational Trial to Assess Real-World Efficacy of MDMA Treatment
09 nov. 2023 08h55 HE
|
PharmAla Biotech
PharmAla partners with Heroic Hearts Canada and the University of Calgary to launch the world's first observational rial into MDMA's real-world efficacy
Canadian Psychedelic Trade Association Endorses Senate Report Calling for Research into Psychedelic-Assisted Therapy
08 nov. 2023 16h50 HE
|
Psychedelics Canada
PsyCan Endorses Senate Report into Psychedelic Treatments for Veterans
PharmAla Partners with Clariti Strategic Advisors™
08 nov. 2023 08h55 HE
|
PharmAla Biotech
PharmAla signs long-term partnership with Clariti Strategic Partners as its investment banking and advisory firm
PharmAla Completes Historic First Shipment of MDMA and Psilocybin to Cortexa
07 nov. 2023 08h55 HE
|
PharmAla Biotech
PharmAla completes the historic first shipment of MDMA and Psilocybin to its Australian Joint Venture, Cortexa, for use in commercial patient treatments